James Marsh

Career chronology

• 15 years before subsequent roles: Imerys Minerals Limited — Technical Manager / global kaolin calcination team. Executive Leadership Significantly Strengthened (pp. 1–2, appointment release, Imerys experience and technical responsibilities)

• 30 May 2018 to 1 April 2023: Andromeda Metals Limited — Managing Director/CEO, then Executive Director – Sales & Marketing. Annual Report 2023 (p. 49, directors report biography and role transition)

• From 9 September 2024: Zeotech Limited — Chief Executive Officer. Annual Report 2025 (p. 24, Marsh service agreement)

Education and qualifications

Education and professional qualification

As reported by cited source; accessed 2026-10-09 · issuer reported · low materiality

The issuer reports a BSc (Honours) from the University of the West of England; Andromeda’s 2023 annual report also identifies BSc (Hons) and MAusIMM. Credential verification remains outside these public-source checks.

Attribution: Responsibility not applicable. Credential statements are issuer-reported; no university or professional-body verification was obtained.

Relevance: Relevant to role-fit assessment and subject to verification gap.

Our People (Our People, James Marsh biography, lines 5–8)

Contributions and company outcomes

FY2026 project and commercial milestones

FY2026 through 2026-06-30; subsequent status through 2026-09-21 · issuer reported · medium materiality

During the cited period Zeotech reported the binding MSI DSO offtake, 2,300-tonne test-pit campaign, AusPozz concrete demonstration and methane-control field results, while Toondoon remained pre-commercial with approvals/logistics still progressing. These are company-level outcomes; the evidence does not isolate CEO's personal contribution or establish booked DSO/AusPozz sales.

Attribution: Role overlaps event; causation unproven. Management responsibility overlapped the company period, but personal causal contribution is not documented.

Relevance: Relevant to delivery assessment; distinguish test/contract milestones from commercial production and realized cash revenue.

Annual Report to shareholders (FY2026 annual report, CEO/operating report); Quarterly Activities and Appendix 5B Cash Flow Report (pp. 1–8, activities report)

Kaolin development leadership at Andromeda; project remained pre-production

2018-05-30 to 2023-03-31 · issuer reported · medium materiality

Andromeda’s 2023 annual report records Marsh as Managing Director from 30 May 2018 to 31 March 2023, followed by Executive Director – Sales & Marketing. Its Great White Project reached a 2023 DFS stage with a 15.1 Mt reserve and construction-ready permits, but funding and investment decision remained prerequisites to development. The report does not quantify Marsh’s personal contribution; these are employer outcomes during his role.

Attribution: Role overlaps event; causation unproven. Marsh held senior executive responsibilities; the company report does not establish individual causal contribution to the DFS, reserve or permits.

Relevance: Relevant industrial-minerals experience with an execution caveat: study/permit milestones did not equal producing operations during his tenure.

Annual Report 2023 (pp. 15–17 project readiness; p. 49 appointment and role chronology; p. 83 funding caveat)

Business failures and setbacks

Pre-commercial status and funding dependence

FY2026 to 2026-06-30 · issuer reported · medium materiality

FY2026 reporting showed the Group remained pre-commercial, with a larger annual loss and operating cash outflow than the prior year; the annual report disclosed that additional funding may be needed to continue operations and develop assets. This is a company-level execution/funding risk during the executive's tenure, not evidence of personal misconduct or sole responsibility.

Attribution: Role overlaps event; causation unproven. The CEO role overlapped the reported period; no personal causal attribution is established.

Relevance: Material to assessing delivery and capital allocation for a development-stage company.

Annual Report to shareholders (FY2026 annual report, financial statements and going-concern funding risk)

Suitability for the current role

Role relevance and evidenced background

Background reviewed through 2026-10-09 · analyst inference · low materiality

The issuer reports 30+ years in industrial minerals and advanced materials, 15 years at Imerys and a BSc (Honours) from the University of the West of England. Current title in the selected roster: Chief Executive Officer. This supports role relevance at a high level; the public evidence reviewed does not establish personal causal responsibility for employer or project outcomes.

Attribution: Responsibility not applicable. Role-fit judgment based on the selected roster and issuer-reported professional background; no causal claim is made.

Relevance: Relevant to the current Chief Executive Officer responsibilities, subject to the evidence limitations recorded below.

Our People (Executive biography or corporate-directory entry for the named person)

Evidence gaps

• Detailed exact dates for Imerys, Minerals Corporation and Active Minerals roles and complete concurrent board interests are not independently verified.

• Andromeda outcomes were company-level; personal causal contribution and subsequent appellate/legal outcomes were not established.

• No exhaustive criminal, sanctions, court, regulator, safety, environment or qualification check was performed.